U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632573) titled 'A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult' on May 26.
Brief Summary: A Phase 1, 2-part, randomised, double-blind, placebo-controlled, FIH study to determine the safety, tolerability, and PK of single, ascending oral doses (SAD) of BDHK-2009 (Part 1) and multiple oral doses (Part 2) of BDHK-200 in healthy adult participants.
Study Start Date: May 18
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis (UC)
Ulcerative Colitis (Disorder)
Ulcerative Colitis Acute
IBD (Inflammatory Bowel Disease)
CD - Crohn's Disease
Intervention:
DRUG: BDHK-2009 Tablets
Administration: Oral
DRUG...